Works by Okamoto, Isamu

Results: 179

Clinical development of nintedanib for advanced non-small-cell lung cancer.

Published in:

2015

By:

Masayuki Takeda;
Isamu Okamoto;
Kazuhiko Nakagawa;
Takeda, Masayuki;
Okamoto, Isamu;
Nakagawa, Kazuhiko

Publication type:

journal article

Phase II Trial of Adjuvant Atezolizumab Therapy in Elderly Patients with Completely Resected Stage II/III Non-Small Cell Lung Cancer: RELIANCE Trial.

Published in:

Clinical Lung Cancer, 2024, v. 25, n. 3, p. 280, doi. 10.1016/j.cllc.2024.01.009

By:

Taichi Matsubara;
Masafumi Yamaguchi;
Mototsugu Shimokawa;
Isamu Okamoto

Publication type:

Article

Nab-Paclitaxel for Previously Treated Advanced Non-Small Cell Lung C ancer: Analysis of Safety and Efficacy for Patients With Renal Impairment.

Published in:

Clinical Lung Cancer, 2022, v. 23, n. 7, p. 585, doi. 10.1016/j.cllc.2022.08.011

By:

Yasuto Yoneshima;
Satoshi Morita;
Masahiko Ando;
Atsushi Nakamura;
Shunichiro Iwasawa;
Hiroshige Yoshioka;
Yasuhiro Goto;
Masafumi Takeshita;
Toshiyuki Harada;
Katsuya Hirano;
Tetsuya Oguri;
Masashi Kondo;
Satoru Miura;
Yukio Hosomi;
Terufumi Kato;
Toshio Kubo;
Junji Kishimoto;
Nobuyuki Yamamoto;
Yoichi Nakanishi;
Isamu Okamoto

Publication type:

Article

Phase I clinical and pharmacokinetic study of the glucose-conjugated cytotoxic agent d-19575 (glufosfamide) in patients with solid tumors.

Published in:

Cancer Chemotherapy & Pharmacology, 2010, v. 65, n. 2, p. 243, doi. 10.1007/s00280-009-1028-3

By:

Shimizu, Toshio;
Okamoto, Isamu;
Tamura, Kenji;
Satoh, Taroh;
Miyazaki, Masaki;
Akashi, Yusaku;
Ozaki, Tomohiro;
Fukuoka, Masahiro;
Nakagawa, Kazuhiko

Publication type:

Article

Exploratory mass cytometry analysis reveals immunophenotypes of cancer treatment-related pneumonitis.

Published in:

eLife, 2024, p. 1, doi. 10.7554/eLife.87288

By:

Toyoshi Yanagihara;
Kentaro Hata;
Keisuke Matsubara;
Kazufumi Kunimura;
Kunihiro Suzuki;
Kazuya Tsubouchi;
Satoshi Ikegame;
Yoshihiro Baba;
Yoshinori Fukui;
Isamu Okamoto

Publication type:

Article

Surfactant protein D prevents mucin overproduction in airway goblet cells via SIRPα.

Published in:

Scientific Reports, 2024, v. 14, n. 1, p. 1, doi. 10.1038/s41598-024-52328-5

By:

Hata, Kentaro;
Tsubouchi, Kazuya;
Suzuki, Kunihiro;
Eto, Daisuke;
Ando, Hiroyuki;
Yanagihara, Toyoshi;
Kan-o, Keiko;
Okamoto, Isamu

Publication type:

Article

Immune Checkpoint Inhibitors for the Treatment of Unresectable Stage III Non–Small Cell Lung Cancer: Emerging Mechanisms and Perspectives.

Published in:

Lung Cancer: Targets & Therapy, 2020, v. 11, p. 161, doi. 10.2147/LCTT.S184380

By:

Inoue, Hiroyuki;
Okamoto, Isamu

Publication type:

Article

Transitional dynamics in oncology clinical trials: evaluating the impact of Clinical Trials Act on cooperative groups.

Published in:

Japanese Journal of Clinical Oncology, 2024, v. 54, n. 7, p. 748, doi. 10.1093/jjco/hyae034

By:

Nakamura, Kenichi;
Takeda, Koji;
Saito, Akiko M;
Kato, Miho;
Sato, Shinya;
Nakagawa, Satoshi;
Kawamoto, Yasuyuki;
Oki, Eiji;
Okamoto, Isamu;
Okamoto, Hiroaki;
Katayama, Hiroshi;
Mizusawa, Junki;
Kaba, Harumi;
Shibata, Taro;
Fukuda, Haruhiko

Publication type:

Article

Osimertinib versus standard-of-care EGFR-TKI as first-line treatment for EGFRm advanced NSCLC: FLAURA Japanese subset.

Published in:

Japanese Journal of Clinical Oncology, 2019, v. 49, n. 1, p. 29, doi. 10.1093/jjco/hyy179

By:

Ohe, Yuichiro;
Imamura, Fumio;
Nogami, Naoyuki;
Okamoto, Isamu;
Kurata, Takayasu;
Kato, Terufumi;
Sugawara, Shunichi;
Ramalingam, Suresh S;
Uchida, Hirohiko;
Hodge, Rachel;
Vowler, Sarah L;
Walding, Andrew;
Nakagawa, Kazuhiko

Publication type:

Article

Phase 3 study of ceritinib vs chemotherapy in ALK-rearranged NSCLC patients previously treated with chemotherapy and crizotinib (ASCEND-5): Japanese subset.

Published in:

Japanese Journal of Clinical Oncology, 2018, v. 48, n. 4, p. 367, doi. 10.1093/jjco/hyy016

By:

Katsuyuki Kiura;
Fumio Imamura;
Hiroshi Kagamu;
Shingo Matsumoto;
Toyoaki Hida;
Kazuhiko Nakagawa;
Miyako Satouchi;
Isamu Okamoto;
Mitsuhiro Takenoyama;
Yasuhito Fujisaka;
Takayasu Kurata;
Masayuki Ito;
Kota Tokushige;
Hatano, Ben;
Makoto Nishio

Publication type:

Article

Characteristics and overall survival of EGFR mutation-positive non-small cell lung cancer treated with EGFR tyrosine kinase inhibitors: a retrospective analysis for 1660 Japanese patients.

Published in:

Japanese Journal of Clinical Oncology, 2016, v. 46, n. 5, p. 462, doi. 10.1093/jjco/hyw014

By:

Akira Inoue;
Kazushi Yoshida;
Satoshi Morita;
Fumio Imamura;
Takashi Seto;
Isamu Okamoto;
Kazuhiko Nakagawa;
Nobuyuki Yamamoto;
Satoshi Muto;
Masahiro Fukuoka

Publication type:

Article

A Phase I Study of Split-dose Cisplatin and Etoposide with Concurrent Accelerated Hyperfractionated Thoracic Radiotherapy in Elderly Patients with Limited-disease Small Cell Lung Cancer.

Published in:

Japanese Journal of Clinical Oncology, 2014, v. 44, n. 8, p. 743, doi. 10.1093/jjco/hyu071

By:

Okamoto, Kunio;
Okamoto, Isamu;
Takeda, Masayuki;
Kobayashi, Shinya;
Takeda, Koji;
Nakamatsu, Kiyoshi;
Nishimura, Yasumasa;
Nakagawa, Kazuhiko

Publication type:

Article

Clinical Impact of Switching to a Second EGFR-TKI After a Severe AE Related to a First EGFR-TKI in EGFR-mutated NSCLC.

Published in:

Japanese Journal of Clinical Oncology, 2012, v. 42, n. 6, p. 528, doi. 10.1093/jjco/hys042

By:

Takeda, Masayuki;
Okamoto, Isamu;
Tsurutani, Junji;
Oiso, Naoki;
Kawada, Akira;
Nakagawa, Kazuhiko

Publication type:

Article

Disturbance of the Growth Hormone–Insulin-like Growth Factor-1 Axis Associated with Poor Performance Status in Patients with Solid Tumors.

Published in:

Japanese Journal of Clinical Oncology, 2010, v. 40, n. 3, p. 222, doi. 10.1093/jjco/hyp155

By:

Okamoto, Isamu;
Munakata, Masaki;
Miyazaki, Masaki;
Satoh, Taroh;
Takahata, Takenori;
Takamatsu, Yasushi;
Muto, Osamu;
Koike, Kazuhiko;
Ishitani, Kunihiko;
Mukaiyama, Taketo;
Sakata, Yuh;
Nakagawa, Kazuhiko;
Tamura, Kazuo

Publication type:

Article

Cisplatin and Etoposide Chemotherapy Combined with Early Concurrent Twice-daily Thoracic Radiotherapy for Limited-disease Small Cell Lung Cancer in Elderly Patients.

Published in:

Japanese Journal of Clinical Oncology, 2010, v. 40, n. 1, p. 54, doi. 10.1093/jjco/hyp137

By:

Okamoto, Kunio;
Okamoto, Isamu;
Takezawa, Ken;
Tachibana, Izumi;
Fukuoka, Masahiro;
Nishimura, Yasumasa;
Nakagawa, Kazuhiko

Publication type:

Article

Phase I Clinical and Pharmacokinetic Study of RAD001 (Everolimus) Administered Daily to Japanese Patients with Advanced Solid Tumors.

Published in:

Japanese Journal of Clinical Oncology, 2010, v. 40, n. 1, p. 17, doi. 10.1093/jjco/hyp120

By:

Okamoto, Isamu;
Doi, Toshihiko;
Ohtsu, Atsushi;
Miyazaki, Masaki;
Tsuya, Asuka;
Kurei, Katsutoshi;
Kobayashi, Ken;
Nakagawa, Kazuhiko

Publication type:

Article

Phase II Study of Carboplatin–Paclitaxel Combination Chemotherapy in Elderly Patients with Advanced Non-small Cell Lung Cancer.

Published in:

Japanese Journal of Clinical Oncology, 2005, v. 35, n. 4, p. 188, doi. 10.1093/jjco/hyi059

By:

Okamoto, Isamu;
Moriyama, Eiji;
Fujii, Shinji;
Kishi, Hiroto;
Nomura, Masanobu;
Goto, Eisuke;
Kiyofuji, Chikage;
Imamura, Fumiya;
Mori, Takashi;
Matsumoto, Mitsuhiro

Publication type:

Article

Interstitial Pneumonia Associated with Nodal T-follicular Helper Cell Lymphoma.

Published in:

Internal Medicine, 2024, v. 63, n. 23, p. 3227, doi. 10.2169/internalmedicine.3601-24

By:

Satoshi Nakamura;
Tomotsugu Takano;
Kousei Nakatsuru;
Kazuya Tsubouchi;
Takuji Yamauchi;
Mikiko Hashisako;
Takeshi Iwasaki;
Isamu Okamoto

Publication type:

Article

An Autopsy Case of COVID-19 with New Diffuse Pulmonary Ossification.

Published in:

Internal Medicine, 2024, v. 63, n. 10, p. 1459, doi. 10.2169/internalmedicine.3096-23

By:

Taisuke Nakagawa;
Yasuaki Kotetsu;
Katsumi Takizawa;
Michihiro Yoshimi;
Isamu Okamoto;
Shohei Takata

Publication type:

Article

Predicting osimertinib‐treatment outcomes through EGFR mutant‐fraction monitoring in the circulating tumor DNA of EGFR T790M‐positive patients with non‐small cell lung cancer (WJOG8815L).

Published in:

Molecular Oncology, 2021, v. 15, n. 1, p. 126, doi. 10.1002/1878-0261.12841

By:

Sakai, Kazuko;
Takahama, Takayuki;
Shimokawa, Mototsugu;
Azuma, Koichi;
Takeda, Masayuki;
Kato, Terufumi;
Daga, Haruko;
Okamoto, Isamu;
Akamatsu, Hiroaki;
Teraoka, Shunsuke;
Ono, Akira;
Ohira, Tatsuo;
Yokoyama, Toshihide;
Yamamoto, Nobuyuki;
Nakagawa, Kazuhiko;
Nishio, Kazuto

Publication type:

Article

A propensity score-matched analysis of the impact of statin therapy on the outcomes of patients with non-small-cell lung cancer receiving anti-PD-1 monotherapy: a multicenter retrospective study.

Published in:

BMC Cancer, 2022, v. 22, n. 1, p. 1, doi. 10.1186/s12885-022-09385-8

By:

Takada, Kazuki;
Shimokawa, Mototsugu;
Takamori, Shinkichi;
Shimamatsu, Shinichiro;
Hirai, Fumihiko;
Tagawa, Tetsuzo;
Okamoto, Tatsuro;
Hamatake, Motoharu;
Tsuchiya-Kawano, Yuko;
Otsubo, Kohei;
Inoue, Koji;
Yoneshima, Yasuto;
Tanaka, Kentaro;
Okamoto, Isamu;
Nakanishi, Yoichi;
Mori, Masaki

Publication type:

Article

Efficacy of platinum agents for stage III non-small-cell lung cancer following platinum-based chemoradiotherapy: a retrospective study.

Published in:

2022

By:

Miyawaki, Eriko;
Kenmotsu, Hirotsugu;
Shintani, Yasushi;
Sekine, Ikuo;
Shukuya, Takehito;
Takayama, Koichi;
Inoue, Akira;
Okamoto, Isamu;
Kiura, Katsuyuki;
Takahashi, Kazuhisa;
Yamamoto, Nobuyuki;
Kawaguchi, Tomoya;
Miyaoka, Etsuo;
Yoshino, Ichiro;
Date, Hiroshi

Publication type:

journal article

Perturbation of the mutated EGFR interactome identifies vulnerabilities and resistance mechanisms.

Published in:

Molecular Systems Biology, 2013, v. 9, n. 1, p. 1, doi. 10.1038/msb.2013.61

By:

Li, Jiannong;
Bennett, Keiryn;
Stukalov, Alexey;
Fang, Bin;
Zhang, Guolin;
Yoshida, Takeshi;
Okamoto, Isamu;
Kim, Jae‐Young;
Song, Lanxi;
Bai, Yun;
Qian, Xiaoning;
Rawal, Bhupendra;
Schell, Michael;
Grebien, Florian;
Winter, Georg;
Rix, Uwe;
Eschrich, Steven;
Colinge, Jacques;
Koomen, John;
Superti‐Furga, Giulio

Publication type:

Article

A phase II study of cisplatin /S-1 in patients with carcinomas of unknown primary site.

Published in:

Investigational New Drugs, 2013, v. 31, n. 6, p. 1568, doi. 10.1007/s10637-013-0014-0

By:

Tsuya, Asuka;
Kurata, Takayasu;
Tamiya, Akihiro;
Okamoto, Isamu;
Ueda, Shinya;
Sakai, Daisuke;
Sugimoto, Naotoshi;
Matsumoto, Koji;
Goto, Isao;
Yamamoto, Nobuyuki;
Fukuoka, Masahiro;
Nakagawa, Kazuhiko

Publication type:

Article

Pemetrexed and carboplatin followed by pemetrexed maintenance therapy in chemo-naïve patients with advanced nonsquamous non-small-cell lung cancer.

Published in:

2013

By:

Okamoto, Isamu;
Aoe, Keisuke;
Kato, Terufumi;
Hosomi, Yukio;
Yokoyama, Akira;
Imamura, Fumio;
Kiura, Katsuyuki;
Hirashima, Tomonori;
Nishio, Makoto;
Nogami, Naoyuki;
Okamoto, Hiroaki;
Saka, Hideo;
Yamamoto, Nobuyuki;
Yoshizuka, Naoto;
Sekiguchi, Risa;
Kiyosawa, Kazuhiro;
Nakagawa, Kazuhiko;
Tamura, Tomohide

Publication type:

Journal Article

Erratum to: Pemetrexed and carboplatin followed by pemetrexed maintenance therapy in chemo-naïve patients with advanced nonsquamous non-small-cell lung cancer.

Published in:

2013

By:

Okamoto, Isamu;
Aoe, Keisuke;
Kato, Terufumi;
Hosomi, Yukio;
Yokoyama, Akira;
Imamura, Fumio;
Kiura, Katsuyuki;
Hirashima, Tomonori;
Nishio, Makoto;
Nogami, Naoyuki;
Okamoto, Hiroaki;
Saka, Hideo;
Yamamoto, Nobuyuki;
Yoshizuka, Naoto;
Sekiguchi, Risa;
Kiyosawa, Kazuhiro;
Nakagawa, Kazuhiko;
Tamura, Tomohide

Publication type:

Journal Article

Pemetrexed and carboplatin followed by pemetrexed maintenance therapy in chemo-naïve patients with advanced nonsquamous non-small-cell lung cancer.

Published in:

Investigational New Drugs, 2013, v. 31, n. 5, p. 1275, doi. 10.1007/s10637-013-9941-z

By:

Okamoto, Isamu;
Aoe, Keisuke;
Kato, Terufumi;
Hosomi, Yukio;
Yokoyama, Akira;
Imamura, Fumio;
Kiura, Katsuyuki;
Hirashima, Tomonori;
Nishio, Makoto;
Nogami, Naoyuki;
Okamoto, Hiroaki;
Saka, Hideo;
Yamamoto, Nobuyuki;
Yoshizuka, Naoto;
Sekiguchi, Risa;
Kiyosawa, Kazuhiro;
Nakagawa, Kazuhiko;
Tamura, Tomohide

Publication type:

Article

Bronchoscopic findings for bevacizumab-related pulmonary hemorrhage in advanced non-small cell lung cancer.

Published in:

2013

By:

Okamoto, Kunio;
Okamoto, Isamu;
Miyazaki, Masaki;
Tanaka, Kaoru;
Kaneda, Hiroyasu;
Nakagawa, Kazuhiko

Publication type:

Report

Erratum to: Pemetrexed and carboplatin followed by pemetrexed maintenance therapy in chemo-naïve patients with advanced nonsquamous non-small-cell lung cancer.

Published in:

2013

By:

Okamoto, Isamu;
Aoe, Keisuke;
Kato, Terufumi;
Hosomi, Yukio;
Yokoyama, Akira;
Imamura, Fumio;
Kiura, Katsuyuki;
Hirashima, Tomonori;
Nishio, Makoto;
Nogami, Naoyuki;
Okamoto, Hiroaki;
Saka, Hideo;
Yamamoto, Nobuyuki;
Yoshizuka, Naoto;
Sekiguchi, Risa;
Kiyosawa, Kazuhiro;
Nakagawa, Kazuhiko;
Tamura, Tomohide

Publication type:

Correction Notice

A phase I study of S-1 with concurrent radiotherapy in elderly patients with locally advanced non-small cell lung cancer.

Published in:

Investigational New Drugs, 2013, v. 31, n. 3, p. 599, doi. 10.1007/s10637-012-9833-7

By:

Hasegawa, Yoshikazu;
Okamoto, Isamu;
Takezawa, Ken;
Miyazaki, Masaaki;
Tsurutani, Junji;
Yonesaka, Kimio;
Morinaga, Ryotaroh;
Tsuya, Asuka;
Terashima, Masaaki;
Kudoh, Toshihiro;
Azuma, Koichi;
Kurata, Takayasu;
Nishikawa, Tatsuyuki;
Fukuoka, Masahiro;
Nishimura, Yasumasa;
Nakagawa, Kazuhiko

Publication type:

Article

Reversible posterior leukoencephalopathy syndrome and trastuzumab.

Published in:

2012

By:

Kaneda, Hiroyasu;
Okamoto, Isamu;
Satoh, Taroh;
Nakagawa, Kazuhiko

Publication type:

Report

Safety and pharmacokinetic study of nab-paclitaxel plus carboplatin in chemotherapy-naïve patients with advanced non-small cell lung cancer.

Published in:

2012

By:

Okamoto, Isamu;
Yamamoto, Nobuyuki;
Kubota, Kaoru;
Ohe, Yuichiro;
Nogami, Naoyuki;
Murakami, Haruyasu;
Yamaya, Hidetoshi;
Ono, Katsuhiro;
Nakagawa, Kazuhiko

Publication type:

Journal Article

Safety and pharmacokinetic study of nab-paclitaxel plus carboplatin in chemotherapy-naïve patients with advanced non-small cell lung cancer.

Published in:

Investigational New Drugs, 2012, v. 30, n. 3, p. 1132, doi. 10.1007/s10637-011-9674-9

By:

Okamoto, Isamu;
Yamamoto, Nobuyuki;
Kubota, Kaoru;
Ohe, Yuichiro;
Nogami, Naoyuki;
Murakami, Haruyasu;
Yamaya, Hidetoshi;
Ono, Katsuhiro;
Nakagawa, Kazuhiko

Publication type:

Article

Perirenal hematoma associated with bevacizumab treatment.

Published in:

2012

By:

Hayashi, Hidetoshi;
Okamoto, Isamu;
Nakagawa, Kazuhiko

Publication type:

Report

Feasibility study of two schedules of sunitinib in combination with pemetrexed in patients with advanced solid tumors.

Published in:

Investigational New Drugs, 2012, v. 30, n. 2, p. 639, doi. 10.1007/s10637-010-9565-5

By:

Okamoto, Isamu;
Shimizu, Toshio;
Miyazaki, Masaki;
Tsurutani, Junji;
Ichikawa, Yasuko;
Terashima, Masaki;
Takeda, Masayuki;
Fumita, Soichi;
Ohki, Emiko;
Kimura, Nobuyuki;
Hashimoto, Junichi;
Nakagawa, Kazuhiko

Publication type:

Article

Phase I clinical and pharmacokinetic study of sorafenib in combination with carboplatin and paclitaxel in patients with advanced non-small cell lung cancer.

Published in:

Investigational New Drugs, 2010, v. 28, n. 6, p. 844, doi. 10.1007/s10637-009-9321-x

By:

Okamoto, Isamu;
Miyazaki, Masaki;
Morinaga, Ryotaro;
Kaneda, Hiroyasu;
Ueda, Shinya;
Hasegawa, Yoshikazu;
Satoh, Taroh;
Kawada, Akira;
Fukuoka, Masahiro;
Fukino, Koichi;
Tanigawa, Takahiko;
Nakagawa, Kazuhiko

Publication type:

Article

Amrubicin for non-small-cell lung cancer and small-cell lung cancer.

Published in:

Investigational New Drugs, 2007, v. 25, n. 5, p. 499, doi. 10.1007/s10637-007-9069-0

By:

Takayasu Kurata;
Isamu Okamoto;
Kenji Tamura;
Masahiro Fukuoka

Publication type:

Article

Proteolytic release of CD44 intracellular domain and its role in the CD44 signaling pathway.

Published in:

Journal of Cell Biology, 2001, v. 155, n. 5, p. 755, doi. 10.1083/jcb.200108159

By:

Okamoto, Isamu;
Kawano, Yoshiaki;
Murakami, Daizo;
Sasayama, Takashi;
Araki, Norie;
Miki, Toru;
Wong, Albert J.;
Saya, Hideyuki

Publication type:

Article

Paired analysis of tumor mutation burden for lung adenocarcinoma and associated idiopathic pulmonary fibrosis.

Published in:

Scientific Reports, 2021, v. 11, n. 1, p. 1, doi. 10.1038/s41598-021-92098-y

By:

Yoneshima, Yasuto;
Iwama, Eiji;
Matsumoto, Shingo;
Matsubara, Taichi;
Tagawa, Testuzo;
Ota, Keiichi;
Tanaka, Kentaro;
Takenoyama, Mitsuhiro;
Okamoto, Tatsuro;
Goto, Koichi;
Mori, Masaki;
Okamoto, Isamu

Publication type:

Article

Continuous monitoring of neutrophils to lymphocytes ratio for estimating the onset, severity, and subsequent prognosis of immune related adverse events.

Published in:

Scientific Reports, 2021, v. 10, n. 1, p. 1, doi. 10.1038/s41598-020-79397-6

By:

Matsukane, Ryosuke;
Watanabe, Hiroyuki;
Minami, Haruna;
Hata, Kojiro;
Suetsugu, Kimitaka;
Tsuji, Toshikazu;
Masuda, Satohiro;
Okamoto, Isamu;
Nakagawa, Takashi;
Ito, Takamichi;
Eto, Masatoshi;
Mori, Masaki;
Nakanishi, Yoichi;
Egashira, Nobuaki

Publication type:

Article

Mass cytometry identifies characteristic immune cell subsets in bronchoalveolar lavage fluid from interstitial lung diseases.

Published in:

Frontiers in Immunology, 2023, v. 14, p. 1, doi. 10.3389/fimmu.2023.1145814

By:

Kentaro Hata;
Toyoshi Yanagihara;
Keisuke Matsubara;
Kazufumi Kunimura;
Kunihiro Suzuki;
Kazuya Tsubouchi;
Daisuke Eto;
Hiroyuki Ando;
Maki Uehara;
Satoshi Ikegame;
Yoshihiro Baba;
Yoshinori Fukui;
Isamu Okamoto

Publication type:

Article

First-line afatinib for the treatment of EGFR mutation-positive non-small-cell lung cancer in the 'real-world' clinical setting.

Published in:

Therapeutic Advances in Medical Oncology, 2019, v. 11, p. 1, doi. 10.1177/1758835919836374

By:

Park, Keunchil;
Wan-Teck Lim, Darren;
Okamoto, Isamu;
Yang, James Chih-Hsin

Publication type:

Article

First-line afatinib for the treatment of EGFR mutation-positive non-small-cell lung cancer in the 'real-world' clinical setting.

Published in:

Therapeutic Advances in Medical Oncology, 2019, v. 11, p. N.PAG, doi. 10.1177/1758835919836374

By:

Park, Keunchil;
Wan-Teck Lim, Darren;
Okamoto, Isamu;
Yang, James Chih-Hsin

Publication type:

Article

The emerging role of epidermal growth factor receptor (EGFR) inhibitors in first-line treatment for patients with advanced non-small cell lung cancer positive for EGFR mutations.

Published in:

Therapeutic Advances in Medical Oncology, 2010, v. 2, n. 5, p. 301, doi. 10.1177/1758834010370698

By:

Okamoto, Isamu;
Mitsudomi, Tetsuya;
Nakagawa, Kazuhiko;
Fukuoka, Masahiro

Publication type:

Article

Correction to: First-line nivolumab plus ipilimumab in metastatic non-small cell lung cancer: 5-year outcomes in Japanese patients from CheckMate 227 Part 1.

Published in:

2023

By:

Nishio, Makoto;
Ohe, Yuichiro;
Ikeda, Satoshi;
Yokoyama, Toshihide;
Hayashi, Hidetoshi;
Fukuhara, Tatsuro;
Sato, Yuki;
Tanaka, Hiroshi;
Hotta, Katsuyuki;
Sugawara, Shunichi;
Daga, Haruko;
Okamoto, Isamu;
Kasahara, Kazuo;
Naito, Tateaki;
Li, Li;
Gupta, Ravi G.;
Bushong, Judith;
Mizutani, Hideaki

Publication type:

Correction Notice

First-line nivolumab plus ipilimumab in metastatic non-small cell lung cancer: 5-year outcomes in Japanese patients from CheckMate 227 Part 1.

Published in:

International Journal of Clinical Oncology, 2023, v. 28, n. 10, p. 1354, doi. 10.1007/s10147-023-02390-2

By:

Nishio, Makoto;
Ohe, Yuichiro;
Ikeda, Satoshi;
Yokoyama, Toshihide;
Hayashi, Hidetoshi;
Fukuhara, Tatsuro;
Sato, Yuki;
Tanaka, Hiroshi;
Hotta, Katsuyuki;
Sugawara, Shunichi;
Daga, Haruko;
Okamoto, Isamu;
Kasahara, Kazuo;
Naito, Tateaki;
Li, Li;
Gupta, Ravi G.;
Bushong, Judith;
Mizutani, Hideaki

Publication type:

Article

First-line durvalumab plus platinum-etoposide in extensive-stage small-cell lung cancer: CASPIAN Japan subgroup analysis.

Published in:

International Journal of Clinical Oncology, 2021, v. 26, n. 6, p. 1073, doi. 10.1007/s10147-021-01899-8

By:

Hotta, Katsuyuki;
Nishio, Makoto;
Saito, Haruhiro;
Okamoto, Isamu;
Nakahara, Yasuharu;
Hayashi, Hidetoshi;
Hayama, Manabu;
Laud, Peter;
Jiang, Haiyi;
Paz-Ares, Luis;
Azuma, Koichi

Publication type:

Article

Japanese subgroup analysis of a phase III study of S-1 versus docetaxel in non-small cell lung cancer patients after platinum-based treatment: EAST-LC.

Published in:

International Journal of Clinical Oncology, 2019, v. 24, n. 5, p. 485, doi. 10.1007/s10147-019-01396-z

By:

Sugawara, Shunichi;
Nakagawa, Kazuhiko;
Yamamoto, Nobuyuki;
Nokihara, Hiroshi;
Ohe, Yuichiro;
Nishio, Makoto;
Takahashi, Toshiaki;
Goto, Koichi;
Maemondo, Makoto;
Ichinose, Yukito;
Seto, Takashi;
Sakai, Hiroshi;
Gemma, Akihiko;
Imamura, Fumio;
Shingyoji, Masato;
Saka, Hideo;
Inoue, Akira;
Takeda, Koji;
Okamoto, Isamu;
Kiura, Katsuyuki

Publication type:

Article

High-dose dexamethasone plus antihistamine prevents colorectal cancer patients treated with modified FOLFOX6 from hypersensitivity reactions induced by oxaliplatin.

Published in:

International Journal of Clinical Oncology, 2011, v. 16, n. 3, p. 244, doi. 10.1007/s10147-010-0170-6

By:

Kidera, Yasuhiro;
Satoh, Taroh;
Ueda, Shinya;
Okamoto, Wataru;
Okamoto, Isamu;
Fumita, Soichi;
Yonesaka, Kimio;
Hayashi, Hidetoshi;
Makimura, Chihiro;
Okamoto, Kunio;
Kiyota, Hidemi;
Tsurutani, Junji;
Miyazaki, Masaki;
Yoshinaga, Masahiro;
Fujiwara, Kimiko;
Yamazoe, Yuzuru;
Moriyama, Kenzo;
Tsubaki, Masanobu;
Chiba, Yasutaka;
Nishida, Shozo

Publication type:

Article

Retreatment of recurrent malignant pleural mesothelioma with cisplatin and pemetrexed.

Published in:

International Journal of Clinical Oncology, 2010, v. 15, n. 5, p. 497, doi. 10.1007/s10147-010-0064-7

By:

Hayashi, Hidetoshi;
Okamoto, Isamu;
Ichikawa, Yasuko;
Miyazaki, Masaki;
Yoshioka, Hiroshige;
Kunimasa, Kei;
Nakagawa, Kazuhiko

Publication type:

Article